Literature DB >> 15920

Stimulation of microsomal NADPH oxidation by quinone group-containing anticancer chemicals.

K Handa, S Sato.   

Abstract

Several anticancer chemicals containing a quinone group were found to stimulate the aerobic oxidation of NADPH by liver microsomes. The enzyme responsible for the above reaction was identified as NADPH-cytochrome c reductase (EC 1.6.2.4), one of the microsomal flavoproteins. The fact that a catalytic amount (20 micronM) of these anticancer chemicals was sufficient to oxidize all the NADPH (100 micronM) indicates that they function as electron carries from the flavoprotein to molecular oxygen. As a corollary, Mitomycin-C and Carbazilquinone stimulated oxygen uptake by Ehrlich ascites tumor cells in the presence of glucose that Daunomycin and Adriamycin failed to do so, although the reason for it remains to be elucidated. Carbazilquinone, in contrast to others, also stimulated the microsomal NADH oxidation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 15920

Source DB:  PubMed          Journal:  Gan        ISSN: 0016-450X


  11 in total

1.  Microsomal lipid peroxidation induced by adriamycin, epirubicin, daunorubicin and mitoxantrone: a comparative study.

Authors:  G F Vile; C C Winterbourn
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  A computational study on the relative reactivity of reductively activated 1,4-benzoquinone and its isoelectronic analogs.

Authors:  Y H Mariam; A Sawyer
Journal:  J Comput Aided Mol Des       Date:  1996-10       Impact factor: 3.686

Review 3.  Redox cycling of radical anion metabolites of toxic chemicals and drugs and the Marcus theory of electron transfer.

Authors:  R P Mason
Journal:  Environ Health Perspect       Date:  1990-07       Impact factor: 9.031

4.  The effect of chronic adriamycin treatment on heart kidney and liver tissue of male and female rat.

Authors:  R H Julicher; L Sterrenberg; G R Haenen; A Bast; J Noordhoek
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

5.  Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.

Authors:  J A Khawly; P Saloupis; D L Hatchell; R Machemer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

6.  Effects of chronic administration of doxorubicin on plasma levels of prostaglandins, thromboxane B2, and fatty acids in rats.

Authors:  T W Robison; S N Giri
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Anthracycline cardiomyopathy.

Authors:  N L Kobrinsky; N K Ramsay; W Krivit
Journal:  Pediatr Cardiol       Date:  1982       Impact factor: 1.655

8.  Mitoxantrone: propensity for free radical formation and lipid peroxidation--implications for cardiotoxicity.

Authors:  R F Novak; E D Kharasch
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

Review 9.  Structure-activity relationships in the free-radical metabolism of xenobiotics.

Authors:  C F Chignell
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031

10.  Polyoxyethylene-modified superoxide dismutase reduces side effects of adriamycin and mitomycin C.

Authors:  S Kawasaki; S Akiyama; T Kurokawa; M Kataoka; K Dohmitsu; K Kondoh; M Yamauchi; K Ito; T Watanabe; S Sugiyama
Journal:  Jpn J Cancer Res       Date:  1992-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.